Bromberg M E, Konigsberg W H, Madison J F, Pawashe A, Garen A
Department of Medicine, Yale University School of Medicine, New Haven, CT 06520-8024, USA.
Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8205-9. doi: 10.1073/pnas.92.18.8205.
Several studies have established a link between blood coagulation and cancer, and more specifically between tissue factor (TF), a transmembrane protein involved in initiating blood coagulation, and tumor metastasis. In the study reported here, a murine model of human melanoma metastasis was used for two experiments. (i) The first experiment was designed to test the effect of varying the level of TF expression in human melanoma cells on their metastatic potential. Two matched sets of cloned human melanoma lines, one expressing a high level and the other a low level of the normal human TF molecule, were generated by retroviral-mediated transfections of a nonmetastatic parental line. The metastatic potential of the two sets of transfected lines was compared by injecting the tumor cells into the tail vein of severe combined immunodeficiency (SCID) mice and later examining the lungs and other tissues for tumor development. Metastatic tumors were detected in 86% of the mice injected with the high-TF lines and in 5% of the mice injected with the low-TF lines, indicating that a high TF level promotes metastasis of human melanoma in the SCID mouse model. This TF effect on metastasis occurs with i.v.-injected melanoma cells but does not occur with primary tumors formed from s.c.-injected melanoma cells, suggesting that TF acts at a late stage of metastasis, after tumor cells have escaped from the primary site and entered the blood. (ii) The second experiment was designed to analyze the mechanism by which TF promotes melanoma metastasis. The procedure involved testing the effect on metastasis of mutations in either the extracellular or cytoplasmic domains of the transmembrane TF molecule. The extracellular mutations introduced two amino acid substitutions that inhibited initiation by TF of the blood-coagulation cascade; the cytoplasmic mutation deleted most of the cytoplasmic domain without impairing the coagulation function of TF. Several human melanoma lines expressing high levels of either of the two mutant TF molecules were generated by retroviral-mediated transfection of the corresponding TF cDNA into the nonmetastatic parental melanoma line, and the metastatic potential of each transfected line was tested in the SCID mouse model. Metastases occurred in most mice injected with the melanoma lines expressing the extracellular TF mutant but were not detected in most mice injected with the melanoma lines expressing the cytoplasmic TF mutant. Results with the extracellular TF mutant indicate that the metastatic effect of TF in the SCID mouse model does not involve products of the coagulation cascade. Results with the cytoplasmic TF mutant indicate that the cytoplasmic domain of TF is important for the metastatic effect, suggesting that the TF could transduce a melanoma cell signal that promotes metastasis.
多项研究证实了血液凝固与癌症之间的联系,更具体地说,是参与启动血液凝固的跨膜蛋白组织因子(TF)与肿瘤转移之间的联系。在本文报道的研究中,人类黑色素瘤转移的小鼠模型被用于两项实验。(i)第一个实验旨在测试改变人类黑色素瘤细胞中TF表达水平对其转移潜能的影响。通过逆转录病毒介导的非转移性亲代细胞系转染,产生了两组匹配的克隆人类黑色素瘤细胞系,一组表达高水平的正常人TF分子,另一组表达低水平的正常人TF分子。通过将肿瘤细胞注入严重联合免疫缺陷(SCID)小鼠的尾静脉,然后检查肺部和其他组织中肿瘤的发展情况,比较两组转染细胞系的转移潜能。在注射高TF细胞系的小鼠中,86%检测到转移性肿瘤,而在注射低TF细胞系的小鼠中,这一比例为5%,表明高TF水平促进了人类黑色素瘤在SCID小鼠模型中的转移。TF对转移的这种作用在静脉注射黑色素瘤细胞时出现,但在皮下注射黑色素瘤细胞形成的原发性肿瘤中未出现,这表明TF在肿瘤细胞从原发部位逃逸并进入血液后的转移后期起作用。(ii)第二个实验旨在分析TF促进黑色素瘤转移的机制。该实验过程包括测试跨膜TF分子细胞外或细胞质结构域突变对转移的影响。细胞外突变引入了两个氨基酸替代,抑制了TF启动血液凝固级联反应;细胞质突变删除了大部分细胞质结构域,而不损害TF的凝血功能。通过逆转录病毒介导将相应的TF cDNA转染到非转移性亲代黑色素瘤细胞系中,产生了几种表达两种突变TF分子中任一种的高水平的人类黑色素瘤细胞系,并在SCID小鼠模型中测试了每个转染细胞系的转移潜能。在大多数注射表达细胞外TF突变体的黑色素瘤细胞系的小鼠中发生了转移,但在大多数注射表达细胞质TF突变体的黑色素瘤细胞系的小鼠中未检测到转移。细胞外TF突变体的结果表明,TF在SCID小鼠模型中的转移作用不涉及凝血级联反应的产物。细胞质TF突变体的结果表明,TF的细胞质结构域对转移作用很重要,这表明TF可能转导一种促进转移的黑色素瘤细胞信号。